The impact of the introduction of smoke-free legislation on prescribing of stop- smoking medications in England

Oct-11

AUTHORS : Dr Lisa Szatkowski, University of Nottingham School of Medicine, Division of Epidemiology and Public Health, Clinical Sciences Building, Nottingham City Hospital, Nottingham NG5 1PB, UK – Email: lisa.szatkowski@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/lisa.szatkowski

JOURNAL : Addiction

REFERENCE: 106(10):1827-34

DOI : 10.1111/j.1360-0443.2011.03494.x

The impact of the introduction of smoke-free legislation on prescribing of stop- smoking medications in England

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study